The monthly out-of-pocket cost is less than the $349 price for monthly injections, but the savings vary by dose.

Eli Lilly (the company behind Mounjaro and Zepbound) just announced impressive phase 3 clinical trial results for a new weight loss medication, orforglipron, a GLP-1. Orforglipron is an oral ...

What if treating obesity could be as easy as popping an effective pill? That's a notion that has long fueled hope for many of the more than 40% of Americans who are considered obese — and fueled ...

To make it easier for children with asthma to receive care at school, a new study will assess the impact of making the ...